BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28222064)

  • 1. Kyleena--another hormonal IUD.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):38-39. PubMed ID: 28222064
    [No Abstract]   [Full Text] [Related]  

  • 2. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms.
    Appiani FJ; Carroll BT
    Ann Clin Psychiatry; 2014 May; 26(2):146-7. PubMed ID: 24812652
    [No Abstract]   [Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
    Nelson AL
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):833-842. PubMed ID: 28617060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing intrauterine system causes a lichenoid drug eruption.
    Jones JA; Shuler MJ; Zlotoff BJ
    Cutis; 2015 Jul; 96(1):E13-5. PubMed ID: 26244359
    [No Abstract]   [Full Text] [Related]  

  • 5. Marked increase of breast density due to a levonorgestrel-releasing intrauterine device.
    Gossner J
    JBR-BTR; 2013; 96(6):396. PubMed ID: 24617194
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing persistent ovarian follicles in premenopausal women fitted with the levonorgestrel-releasing intrauterine system.
    Morelli M; Di Cello A; Zullo F
    Int J Gynaecol Obstet; 2013 Feb; 120(2):187. PubMed ID: 23195289
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mirena--the first intrauterine contraceptive therapeutic system].
    Rachev E
    Akush Ginekol (Sofiia); 2001; 40 Suppl 6():3-6. PubMed ID: 11803883
    [No Abstract]   [Full Text] [Related]  

  • 8. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
    Karri K; Mowbray D; Adams S; Rendal JR
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of Crohn's disease after insertion of a levonorgestrel intrauterine system: a case report.
    Wakeman J
    J Fam Plann Reprod Health Care; 2003 Jul; 29(3):154. PubMed ID: 12885311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device.
    Dueñas-Garcia OF; Young C
    Int J Gynaecol Obstet; 2011 Aug; 114(2):153-4. PubMed ID: 21679948
    [No Abstract]   [Full Text] [Related]  

  • 14. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial.
    Whitaker AK; Endres LK; Mistretta SQ; Gilliam ML
    Contraception; 2014 Jun; 89(6):534-9. PubMed ID: 24457061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer non-oral hormonal contraception.
    Bateson D; McNamee K; Briggs P
    BMJ; 2013 Feb; 346():f341. PubMed ID: 23412438
    [No Abstract]   [Full Text] [Related]  

  • 17. Gynaecological aspects of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Br J Obstet Gynaecol; 1997 Mar; 104(3):285-9. PubMed ID: 9091003
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden.
    Marions L; Lövkvist L; Taube A; Johansson M; Dalvik H; Øverlie I
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):126-34. PubMed ID: 21417562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ▼Jaydess IUS.
    Drug Ther Bull; 2015 Jan; 53(1):9-12. PubMed ID: 25592689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of levonorgestrel intra-uterine system in idiopathic menorrhagia.
    Chattopdhyay B; Nigam A; Goswami S; Chakravarty PS
    Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):764-8. PubMed ID: 21780544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.